James Rolke - Feb 11, 2025 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Executive Officer, Director
Signature
/s/ J.P. Galda, as attorney-in-fact for James Rolke
Stock symbol
REVB
Transactions as of
Feb 11, 2025
Transactions value $
$116,468
Form type
4
Date filed
2/13/2025, 06:07 PM
Previous filing
Feb 28, 2023
Next filing
Oct 31, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Award $116K +30.1K +71654.76% $3.87 30.1K Feb 11, 2025 Direct F1
holding REVB Common Stock 42 Feb 11, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.